Approval · Notice of Compliance 1854 · 1999
EXTRANEAL: Notice of Compliance 1854
Issued September 17, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1854
- Date
- September 17, 1999
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Peritoneal dialysis solution
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXTRANEAL | 02240806 | Marketed |
Medicinal ingredients
- ICODEXTRIN 75 G per L